# PURIXAN
> **NDA205919** · New Drug Application · Sponsor: NOVA LABS LTD · Approved 2014-04-28
## Drug
- **FDA Application Number:** NDA205919
- **Application type:** New Drug Application
- **Brand name:** PURIXAN
- **Generic name:** MERCAPTOPURINE
- **Active ingredients:** MERCAPTOPURINE
- **Dosage form:** SUSPENSION
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** NOVA LABS LTD
- **Manufacturer:** Nova Laboratories, Ltd
- **First approval:** 2014-04-28
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205919)
---
*AI Analytics · CC0 1.0*